CL2017001679A1 - Uso de extractos de quillaja saponaria para la prevención y control de infecciones bacterianas en peces - Google Patents

Uso de extractos de quillaja saponaria para la prevención y control de infecciones bacterianas en peces

Info

Publication number
CL2017001679A1
CL2017001679A1 CL2017001679A CL2017001679A CL2017001679A1 CL 2017001679 A1 CL2017001679 A1 CL 2017001679A1 CL 2017001679 A CL2017001679 A CL 2017001679A CL 2017001679 A CL2017001679 A CL 2017001679A CL 2017001679 A1 CL2017001679 A1 CL 2017001679A1
Authority
CL
Chile
Prior art keywords
fish
prevention
control
extracts
keel
Prior art date
Application number
CL2017001679A
Other languages
English (en)
Inventor
Suárez Trinidad Schlotterbeck
Jones Hernán Alberto Cañon
Ruiz Mario Hernán Castillo
González Hernán Danilo Cortés
Martín Gamboa Ricardo Manuel Guillermo San
Original Assignee
Saponin Res Center S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saponin Res Center S A filed Critical Saponin Res Center S A
Publication of CL2017001679A1 publication Critical patent/CL2017001679A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Physiology (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

<p>La presente invención proporciona un nuevo uso de extractos de quillay útiles para fabricar una composición medicinal para la prevención y control de una enfermedad bacteriana en peces, la que se administra por vía oral preferentemente en combinación con un alimento. Otros objetos de invención se relacionan con la composición medicinal y la composición alimentaria para la prevención y control de una enfermedad bacteriana en peces que comprenden dichos extractos de quillay.</p>
CL2017001679A 2016-07-29 2017-06-23 Uso de extractos de quillaja saponaria para la prevención y control de infecciones bacterianas en peces CL2017001679A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CL2016/050044 WO2018018170A1 (es) 2016-07-29 2016-07-29 Uso de extractos de quillaja saponaria para la prevención y control de infecciones bacterianas en peces

Publications (1)

Publication Number Publication Date
CL2017001679A1 true CL2017001679A1 (es) 2018-03-23

Family

ID=61015537

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017001679A CL2017001679A1 (es) 2016-07-29 2017-06-23 Uso de extractos de quillaja saponaria para la prevención y control de infecciones bacterianas en peces

Country Status (5)

Country Link
US (2) US20180325970A1 (es)
CA (1) CA2972175C (es)
CL (1) CL2017001679A1 (es)
NO (1) NO345485B1 (es)
WO (1) WO2018018170A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1027041B1 (nl) * 2019-02-08 2020-09-08 Nutrition Sciences Nv Samenstelling voor gebruik bij de behandeling van piscirickettsiose
KR20230028309A (ko) 2020-05-26 2023-02-28 밴티지 스페셜티 케미컬스, 아이엔씨. 유기 수성 이형 코팅

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001051083A2 (en) 2000-01-13 2001-07-19 Antigenics Inc. Innate immunity-stimulating compositions of cpg and saponin and methods thereof
US20050074508A1 (en) 2002-12-03 2005-04-07 Ricardo San Martin Compositions and methods based on exracts of quillaja saponaria molina for controlling nematodes
EP2484374A1 (en) * 2004-07-18 2012-08-08 CSL Limited Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses
US20070196517A1 (en) 2005-07-13 2007-08-23 Dictuc S.A. Modified Saponin Molluscicide
US20080226682A1 (en) * 2007-03-13 2008-09-18 Peros Systems Technologies, Inc. Immunoactive Compositions for Improved Oral Delivery of Vaccines and Therapeutic Agents
MX2015003825A (es) * 2012-09-26 2015-11-06 Fvg Ltd Subunidades de vacunas de inmersion para peces.
CA2945249A1 (en) 2014-04-09 2015-10-15 Biomar Group A/S Compound or composition for use in the prevention and/or treatment of an ectoparasitic copepod infestation or infection in fish
CN106659787A (zh) 2014-05-23 2017-05-10 辉宝动物保健公司 组合、组合物及向动物施用所述组合或组合物的方法

Also Published As

Publication number Publication date
NO20171171A1 (en) 2017-07-13
US20180325970A1 (en) 2018-11-15
CA2972175C (en) 2022-03-01
WO2018018170A1 (es) 2018-02-01
US10987393B2 (en) 2021-04-27
NO345485B1 (en) 2021-03-01
CA2972175A1 (en) 2018-01-29
US20200023026A1 (en) 2020-01-23

Similar Documents

Publication Publication Date Title
CL2016002517A1 (es) Uso de ácido r-2-4-2-etoxi-3-4-trifluormetilfenoxipropil-tio-2-metilfenoxi acético o una sal del mismo en la fabricación de un medicamento para tratar una condición que es una enfermedad de hígado graso no alcohólico o esteatohepatitis no alcohólica.
DOP2017000137A (es) Benzamidas sustituidas con 1,3–tiazol–2–ilo.
CL2016001547A1 (es) Composiciones para el cuidado oral
CL2016001544A1 (es) Composición dentífrica que comprende óxido de zinc y citrato de zinc
CL2015003117A1 (es) Modificaciones en la estructura cristalina
CL2018000222A1 (es) Nueva combinación para el uso en el tratamiento del cáncer
BR112015020118A2 (pt) derivados de 2-aminopirimidina para o tratamento de infecções virais
CL2019003402A1 (es) Composiciones sólidas para administración oral.
CL2016002276A1 (es) Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad
BR112017000313A2 (pt) sistema para o fornecimento de uma composição para tratamento bucal, composição para tratamento bucal, método para administrar uma composição para tratamento bucal
CL2015002755A1 (es) Composiciones antibióticas de ceftolozano.
CL2016002955A1 (es) Composicion de edulcorante que comprende alulosa y un extracto de stevia; producto alimenticio o bebida que comprende la composicion edulcorante; edulcorante de mesa; uso de la composición edulcorante.
CL2016002732A1 (es) Suplementación microbioma neonatal
CL2017001483A1 (es) Formulación de relación fija de insulina glargina/lixisenatida
ES2429422R1 (es) Composición farmacéutica y su uso para preparar un medicamento destinado al tratamiento y la prevención de enfermedades causadas por el VIH
ECSP17015154A (es) Métodos para mejorar el rendimiento miocárdico en pacientes con cirugía de fontan que utilizan composiciones de udenafilo
CL2017001679A1 (es) Uso de extractos de quillaja saponaria para la prevención y control de infecciones bacterianas en peces
DOP2015000089A (es) Composición de difenidol de liberación prolongada
ES2616035T3 (es) Preparación para su uso en la profilaxis y el tratamiento de osteoporosis atípica
CL2017001678A1 (es) Uso de extractos de quillaja saponaria para la prevención y control de infecciones virales en peces
PA8789101A1 (es) Composición farmacéutica estable que comprende una sal de vinflunina hidrosoluble
PL404229A1 (pl) Wyizolowany immunogenny antygen bakteryjny i jego zastosowanie w profilaktyce i leczeniu zakażeń wywołanych przez Gram-ujemne bakterie
CL2019003288A1 (es) Una combinación farmacéutica para el tratamiento de un cáncer.
AR106415A1 (es) Composición farmacéutica para el tratamiento del dolor
ES2475942B1 (es) Composición farmacéutica de citrato de sildenafilo en forma de solución acuosa